Literature DB >> 22242078

A patient's informative mistake: niacin is very effective in correcting dyslipidaemia.

Michelle Fung1, Jiri Frohlich.   

Abstract

A 72-year-old man at high risk for cardiovascular disease, with a history of peripheral vascular disease and type 2 diabetes, presented with lipids above targets despite maximum daily treatment with atorvastatin 80 mg, fenofibrate supra 160 mg daily, and ezetimibe 10 mg. His low density lipoprotein cholesterol (LDL-C) was 2.6 mmol/l, total cholesterol: HDL ratio 5.6, and high density lipoprotein cholesterol (HDL-C) 0.9 mmol/l. Because his lipids were not within target, he was advised to start 2250 mg of niacin in three divided doses daily. For 5 months, he mistakenly took 2250 mg of niacin three times daily, a consumption of 6750 mg/day! The effects on his lipids were: HDL-C increased nearly 100% to 1.7 mmol/l, LDL-C decreased by 50% to 1.3 mmol/l, and cholesterol: HDL ratio decreased by over 50% to 2.1. His excessive intake dramatically demonstrates the positive effect of niacin on lipids. Fortunately he did not suffer adverse effects from taking more than the recommended limit of 3000 mg/day.

Entities:  

Year:  2010        PMID: 22242078      PMCID: PMC3030282          DOI: 10.1136/bcr.06.2009.2028

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Effects of salts of nicotinic acid on serum cholesterol.

Authors:  R ALTSCHUL; A HOFFER
Journal:  Br Med J       Date:  1958-09-20

2.  Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice.

Authors:  Sachin J Kamal-Bahl; Thomas Burke; Douglas Watson; Chuck Wentworth
Journal:  Am J Cardiol       Date:  2006-12-28       Impact factor: 2.778

Review 3.  Safety considerations with niacin therapy.

Authors:  John R Guyton; Harold E Bays
Journal:  Am J Cardiol       Date:  2006-11-28       Impact factor: 2.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.